Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
| ▸ | IDH2 | P48735 | 1/20 | 0.30 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27379299 | 0.84 | HDAC4 (0.36) | SCN5ASCN9AIDH1IDH2GPR119 | |
| SCHEMBL30755433 | 0.84 | HDAC4 (0.36) | SCN5ASCN9AIDH1IDH2GPR119 | |
| SCHEMBL27377777 | 0.81 | GPR119 (0.36) | ALOX5APFEN1TRPV3SCN5ASCN9A | |
| SCHEMBL30755349 | 0.81 | GPR119 (0.36) | ALOX5APFEN1TRPV3SCN5ASCN9A | |
| SCHEMBL27375857 | 0.78 | MEN1 (0.36) | IDH1IDH2P2RX7 | |
| SCHEMBL27378973 | 0.78 | MEN1 (0.38) | IDH1IDH2P2RX7 | |
| SCHEMBL27375885 | 0.78 | CA12 (0.37) | IDH1IDH2P2RX7 | |
| SCHEMBL30755212 | 0.78 | CA12 (0.37) | IDH1IDH2P2RX7 | |
| SCHEMBL30755472 | 0.77 | IDH1 (0.35) | IDH1IDH2P2RX7CNR2 | |
| SCHEMBL27374381 | 0.76 | MEN1 (0.35) | SCN5ASCN9AIDH1IDH2GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024026483-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |